ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and

Venturina Stagni1, Michele Mingardi, Simonetta Santini

  • 1Laboratory of Cell Signaling, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.

Carcinogenesis
|September 30, 2010
PubMed

Insights

Ataxia telangiectasia mutated (ATM) kinase activity is crucial for down-regulating cFLIP proteins following DNA damage, enhancing cancer cells

Area of Science:

  • Molecular Biology
  • Cancer Therapy
  • Cell Death Signaling

Background:

  • Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise for cancer therapy, but many cancers exhibit resistance.
  • cFLIP proteins inhibit TRAIL-induced apoptosis and are often overexpressed in cancers, making them a target for sensitization strategies.
  • DNA-damaging agents like 5-fluorouracil (5-FU) can down-regulate cFLIP, but the underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the role of Ataxia Telangiectasia Mutated (ATM) kinase in the down-regulation of cFLIP proteins upon DNA damage.
  • To determine if ATM activity is required for DNA-damaging agents to sensitize hepatocellular carcinoma (HCC) cells to TRAIL.
  • To elucidate the molecular mechanisms by which ATM influences cFLIP levels and TRAIL sensitivity.

Main Methods:

  • Genetic evidence was used to assess the requirement of ATM kinase activity.
  • Hepatocellular carcinoma (HCC) cell lines were treated with DNA-damaging agents (5-FU, neocarzinostatin).
  • cFLIP protein levels, ubiquitination, and sensitivity to TRAIL were analyzed in response to DNA damage and ATM activity.

Main Results:

  • ATM kinase activity is essential for the down-regulation of both cFLIP(L) and cFLIP(S) isoforms induced by 5-FU and neocarzinostatin.
  • ATM-mediated cFLIP down-regulation sensitizes HCC cell lines to TRAIL-induced apoptosis.
  • ATM enhances cFLIP(L) ubiquitination in response to DNA damage, independent of p53.

Conclusions:

  • ATM kinase acts as a critical mediator linking DNA damage response pathways with death receptor signaling.
  • ATM activity is required for sensitizing cancer cells to TRAIL via DNA-damaging agents.
  • The expression of functional ATM in tumor cells may be vital for the success of combined TRAIL-based and DNA-damaging therapies.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...